Metabolic and nutritional disorders Flashcards
What are the major nutrients required for proper development and growth?
- macronutrients (fat, carbohydrate and protein)
- micronutrients (vitamins and minerals; essential amino acids and fatty acids)
- water
Describe genetically determined errors of metabolism
Metabolic disorder
- generally associated with specific enzyme deficiencies and result in blockage of amino acid, carbohydrate, or lipid metabolism, with reduction of some substances and accumulation of others.
- carrier state can be identified to permit genetic counselling in many disorders by testing of amniotic fluid before birth or appropriate screening at birth
- disorders seldom occur
- many are characterized by autosomal recessive transmission (often chromosome of defective gene has been determined)
- functional and pathological damage may be produced by: loss of end product of a reaction due to enzyme deficiency, accumulation of substances prior to the metabolic block or production of toxic metabolites.
What is Phenylketonuria (PKU)?
- disorder of amino acid metabolism in which the enzyme responsible for the conversion of phenylalanine to tyrosine is deficient.
- results in increased blood levels of phenylalanine - impairs normal brain development - and increased urinary excretion of phenylpyruvic acid
- within the brain there is hypomyelination, gliosis and microcephaly. No lysosomal storage in neurons
What are the clinical features of PKU
- severe mental retardation, seizures, and hyperactivity as well as decreased pigmentation of the hair and skin (due to decreased melanin production from tyrosine)
- women with PKU can be normal with treatment - it is imparative that treatment continue during pregnancy (prior to conception). If not children born are profoundly mentally retarded and have multiple congenital anomalies.
What is the treatment of PKU?
Restriction of phenylalanine in diet and supplementation with tyrosine.
- newborns are screened (Guthrie- test-serum analysis)
What is Galactosemia?
- disorder of carbohydrate metabolism. Deficiency of galactose-1-phospphate uridyl transferase leads to accumulation of galactose-1-phosphate and galactosuria and hypergalactosemia.
- normally this enzyme takes part in one of the steps in which galactose is converted to glucose
What are the clinical features, and diagnosis of galactosemia?
- jaundice, liver damage (fatty change, widespread scarring, hepatomegaly), cataracts, neural damage (nerve cell loss, gliosis, edema).
- accumulation of galactose in the kidney impairs amino acid transport resulting in aminoaciduria.
- without appropriate dietary therapy (i.e. removal of galactose from the diet), long term complications such as cataracts, speech and neurological deficits and mental retardation occur in older children.
- diagnosis can be established by assay of transferase in white or red blood cells; antenatal diagnosis is possible by enzyme assays or DNA analysis.
What is lysosomal storage disease?
- normally lysosomes contain hydrolytic enzymes that are involved in the breakdown of complex substrates
- a lack of lysosomal enzymes, means catabolism of the substrate remains incomplete leading to accumulation of partially degraded insoluble metabolites within the lysosomes.
- over 40 lysosomal storage diseases have been identified (but they are rare)
- can be classified based on the underlying metabolic defect: primary lysosomal hydrolase defect, post-translation processing defect of lysosomal enzymes, and transmembrane protein defects.
- clinical expression is variable when infants and children are affected, progressive mental and motor deteriorate and death is the usual pattern. Many variants tho which have milder forms with adult onset.
What is Tay-Sachs disease (GM2 gangliosidosis)?
- accumulation of gangliosides within the brain as a result of the catabolic enzyme defect - deficiency in the a subunit of hexoaminidase A, necessary for the degradation of GM2.
- affected cells appear swollen or ‘foamy’ with lipid vacuolation
- most common among Ashkenazi Jews (heterozygous carriers = 1 in 30).
- in most common variant, infants appear normal at birth but motor weakness begins to develop at 3-6 months of age, followed by mental retardation, blindness and severe neurologic dysfunction. Death occurs within 2-3 years
What is Niemann-Pick disease? Types A and B
Characterized by a primary deficiency of acid sphingomyelinase and the accumulation of sphingomyelin.
1. Type A: breakdown of sphingomyelin into ceramide and phosphorylcholine is impaired and excess sphingomyelin accumulates in phagocytic cells and neurons. This variant manifests itself in infancy with massive visceromegaly and severe neurological deterioration. Death usually occurs within the first 3 years.
- organs most severely affected are the spleen, liver, bone marrow, lymph nodes, and lungs.
- CNS is involved and affected neurons are enlarged and vacuolated as a result of the storage of lipids.
2. Type B: have organomegaly but no neurologic symptoms.
- estimation of sphingomyelinase activity in leukocytes or cultured fibroblast can be used for diagnosis of suspected cases as well as carriers; antenatal diagnosis is possible by enzyme assays or DNA analysis.
Describe acquired metabolic disorders
Largely due to lifestyle and unhealthy dietary habits (atherosclerosis, obesity and diabetes), exposure to environmental or industrial pollutants or toxins (e.g. carbon monoxide, cyanide, carbon disulphide), or they may be secondary to derangements of renal or liver diseases.
- those associated with hypoxia are the most common. in most cases the underlying cause of hypoxia and ischemia is related to the presence of atherosclerotic plaques in large and medium-sized arteries.
What is Atherosclerosis?
Begins early in life but usually remains clinically silent until it has progressed to the point where it results in disease. The earliest pathological lesion, called a fatty streak, can be found in teenagers. Some of these slowly progress and develop into the mature atherosclerotic lesion, the fibro-fatty plaque which narrows the vessel lumen.
- major modifiable risks for atherosclerosis are:
1. hypertension
2. hyperlipidemia (hypercholesterolemia)
3. smoking
4. diabetes mellitus
Other risk factors include obesity, type A personality/ stress, elevated serum homocysteine levels, and inflammation marker - C-reactive protein. Non-modifiable risks include age, sex (male> female) and family history.
What is diabetes mellitus?
A complex metabolic derangement characterized by either a relative or absolute lack of insulting resulting in hyperglycaemia. Results from defects in insulin secretion, insulin action or both.
- chronic hyperglycaemia and the metabolic dysregulation of diabetes is associated with damage in many organ systems, particularly the kidney, eyes, nerves and blood vessels.
There is type 1 and type 2 diabetes
Describe type 1 diabetes
Insulin-dependent; juvenile-onset
- few if any functional beta cells in the pancreatic islets of Langerhans and substantially reduced or no insulin secretion (an absolute deficiency of insulin).
- usually develops during childhood, peak incidence at puberty
- body fat is metabolized as a source of energy and its oxidation produces ketone bodies that lead to metabolic acidosis.
- glucose is markedly increased in the blood and urine.
- prominent symptoms include increased urine output (polyuria), increased thirst (polydipsia) and weight loss.
- has complex pattern of genetic association; between 90-95% express HLA-DR3 or DR4 (class MHC II alleles).
- autoimmune pathogenesis is supported by the presence of an infiltrate of mononuclear cells in and around the islets of Langerhands. Evidence suggest that sensitized cytotoxic T lymphocytes damage the beta cells, and also evidence that environmental factors may be involved (e.g. viruses).
Describe type 2 diabetes
Reflects a failure of the beta cells to meet an increased demand for insulin. Almost 10% of persons over 65 years are affected and 80% of persons with type 2 are overweight.
- Caused by a combination of peripheral resistance to insulin action and an inadequate response of insulin secretion by the pancreatic-B-cells i.e. a relative insulin deficiency.
- Approximately 80-90% of those with diabetes have type 2.
- Pathogenesis is still unknown, but both environmental and genetic factors play a role. Multifactorial inheritance is a key factor in the development of Type 2 (e.g. mutation in glucokinase gene found in one inherited form, but pure genetic forms are rare. 60% of patients have either a parent or a sibling with the disease; concordance rates in identical or fraternal twins are significantly higher than in the population at large.
- Sedentary lifestyle and poor dietary habits that lead to obesity increase the risk for developing diabetes (risk for type 2 increases as the body mass index increases).
- Insulin resistance, i.e. resistance to the effects of insulin on glucose uptake, metabolism or storage, is characteristic of diabetic individuals, especially those who are obese. Links between obesity and insulin resistance include excessive amounts of free fatty acids (FFAs) and a number of adipocyte-specific products (adipocytokines, e.g. leptin, adiponectin, and resistin)
- Unlike type 1, there is no consistent reduction in the number of beta cells in the pancreas and no morphological lesions. In states of insulin resistance, insulin secretion is initially higher for a given glucose level (a compensatory hyperglycemia). This can often maintain normal glucose for years (a pre-diabetic state). Eventually beta cell hyperplasia becomes inadequate and there is a decrease in beta cell mass and clinical progression.